Dr. Chern, Yijuang 's publons link picture Dr. Chern, Yijuang 's Youtube

Dr. Chern, Yijuang

Director
Distinguished Research Fellow
  • +886227899028 (Lab) (Room No: N333)
  • +886226523913 (Office)
  • 02-27829143 (Fax)

Specialty:
  • Signal Transduction
  • Gene Regulation
  • Neurodegeneration Disease

Education and Positions:
  • Ph.D. Univ. of Massachusetts


Dr. Chern, Yijuang 's
Publications

Journal 138 Book 4

  1. Chang Y-C, Tsai Y-C, Chang E-C, Hsu Y-C, Huang Y-R, Lee Y-H, Tsai Y-S, Chen Y-Q, Lee Y-C, Liao Y-C, Kuo J-C, Su M-T, Yang UCξ, (Chern Y)*, Cheng T-H* Altered PIAS1, UBC9, and ATXN3 Interactions by PIAS1 S510G Variant Selectively Reduce Mutant ATXN3.. The International Journal of Biochemistry & Cell Biology 176, 106662 (2024-11) [JCR] [WOS]
  2. Liu Y-J, Lee C-W, Liao Y-C, Huang J J-T, Kkuo H-C, Jih K-Y, Lee Y-C, (Chern Y)* The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS.. Neurobiology of Disease 202, 106715 (2024-10-28) [JCR] [WOS]
  3. Chang C-P, Wu C-W, (Chern Y)* Metabolic Dysregulation in Huntington\'s Disease: Neuronal and Glial Perspectives.. Neurobiology of Disease 201, 106672 (2024-10-15) [JCR] [WOS]
  4. Lu Y-S, Hung W-C, Hsieh Y-T, Tsaai P-Y, Tsai T-H, Fan H-H, Chang Y-G, Cheng H-K, Huang S-Y, Lin H-C, Lee Y-H, Shen T-H, Hung B-Y, Tsai J-W, Dzhagalov I, Cheng I H-J, Lin C-J, (Chern Y), Hsu C-L* Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model. Brain Behavior and Immunity 120, 413-429 (2024-06-24) [JCR] [WOS]
  5. Siew JJ, Chen H-M, Chiu F-L, Lee C-W, Chang Y-M, Chen H-L, Nguyen TNA, Liao H-T, Liu M, Hagar H-T, Sun Y-C, Lai H-L, Kuo M-H, Blum D, Buee L, Jin L-W, Chen S-Y, Ko T-M, Huang J-r, Kuo H-C, Liu F-T, Chern Y* Galectin-3 aggravates microglial activation and tau transmission in tauopathy. JOURNAL OF CLINICAL INVESTIGATION 134(2), e165523 (2024-01-16) [JCR] [WOS]
  6. Ho S-Y, Chen I-C, Tsai C-W, Chang K-C, Lin C-J, Chern Y, Liou H-H* Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome. HIPPOCAMPUS 34(1), 7-13 (2023-11-06) [JCR] [WOS]
  7. Siew Jian Jing, Chern Yijuang, Khoo Kay-Hooi, Angata Takashi Roles of Siglecs in neurodegenerative diseases. Molecular Aspects of Medicine 90, 101141 (2023-04) [JCR] [WOS]
  8. Weng YT, Chang YM, (Chern Y)* The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.. International Journal of Molecular Sciences 24, 3443 (2023-02-08) [JCR] [WOS]
  9. Chen Ching-Ya, Chou Fang-Yi, Chang Ya-Gin, Ho Chin-Jui, Wu Kuo-Chen, Hsu Chia-Lin, Chern Yijuang, Lin Chun-Jung Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington\'s disease. Neurobiology of Disease 177, 106004 (2023-02) [JCR] [WOS]
  10. Chen Kuan-Yu, Lu Chiao-Shin, Pang Cheng-Yoong, Ho Chin-Jui, Wu Kuo-Chen, Yang Hsiu-Wei, Lai Hsin-Lin, Chern Yijuang, Lin Chun-Jung Equilibrative Nucleoside Transporter 1 is a Target to Modulate Neuroinflammation and Improve Functional Recovery in Mice with Spinal Cord Injury. Molecular Neurobiology 60(1), 369-381 (2023-01) [JCR] [WOS]